Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05578092
Title A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Denver Drug Development Unit - HealthONE RECRUITING Denver Colorado 80218 United States Details
Yale University, Yale Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins RECRUITING Baltimore Maryland 21287 United States Details
University of Cincinnati Medical Center RECRUITING Cincinnati Ohio 45219 United States Details
Oregon Health and Science University RECRUITING Portland Oregon 97239 United States Details
SCRI - TN Oncology Nashville Drug Development Unit Clinic RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology Virginia RECRUITING Fairfax Virginia 22031 United States Details
Seattle Cancer Care Alliance RECRUITING Seattle Washington 98109 United States Details
Pan America center for Oncology Trials LLC RECRUITING Rio Piedras 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field